March 2006

Your New Comprehensive Retina Resource

Conni Bergmann Koury Editor-in-Chief

Vitrase Effective for Vitreous Hemorrhage Management

Statistically significant outcomes were seen as early as the month of treatment.

Baruch D. Kuppermann, MD, PhD

Changing Surgical Approaches for Retinal Detachment

Ever-present challenges in vitreoretinal surgery for complicated retinal detachment include visualization, hemorrhage and reproliferation.

Donald J. D'Amico, MD

Is Glycemic Control Necessary During Cataract Surgery in Diabetic Patients?

Merits and demerits of rapid preoperative glycemic correction.

Chikako Suto, MD, and Sadao Hori, MD

Move Over Digital Imaging, Make Room for an Administration System

The UK's Optomize iP combines digital imaging with automated electronic patient administration.

Laura Suarez, Managing Editor

Advances in OCT Improve Understanding of Disease States

Developments have led to successful imaging of several retinal pathologies.

Jay S. Duker, MD

The Future of CRVO, BRVO, and DME Therapies

Most drugs for these diseases, when caused by macular edema, are currently under clinical trial for long-term efficacy.

Michael S. Ip, MD

Targeting VEGF in AMD

Anti-VEGF treatments have revolutionalized AMD therapy.

Rishi P. Singh, MD, and Peter K. Kaiser, MD

Bevacizumab in the Treatment of Ocular Disease

A reduced cost and increased half-life may find bevacizumab as an attractive worldwide treatment choice.

Dante J. Pieramici, MD, and Robert L. Avery, MD

Considerations for Intravitreal Triamcinolone Use

Because ocular injection of this treatment is an off-label use, physicians must consider associated complications and the importance of informed consent.

Laura Suarez, Managing Editor

Considerations for Intravitreal Triamcinolone Use

Because ocular injection of this treatment is an off-label use, physicians must consider associated complications and the importance of informed consent.

Laura Suarez, Managing Editor

Pegaptanib Safety Profile Maintained Through 2 Years

No increased risk of cardiovascular events was seen in patients with neovascular AMD; no additional safety concerns brought to light.

Conni Bergmann Koury, Editor-in-Chief

Prevalence of AMD in Whites, Blacks, Hispanics and Chinese

Data for this study were taken from the second examination of the Multi-Ethnic Study of Atherosclerosis.

Conni Bergmann Koury, Editor-in-Chief

Clinical Trial Update: Macular Diseases

Update on Pharmacologic Treatment of Diabetic Macular Edema

Jointly sponsored by The Dulaney Foundation and Retina Today. Release Date: March 2006. Expiration Date: March 31, 2007. This continuing medical education activity is supported by an educational grant from Eli Lilly and Company.

Glenn J. Jaffe, MD

5 Questions with Lois E.H. Smith, MD, PhD

Dr. Smith, of the Children's Hospital Boston, was awarded the Bressler Prize in Vision Science.

Lois E.H. Smith, MD, PhD